Breast cancer, which is the most common cancer in women, is a major problem both in Poland and worldwide(1). Mammography is the primary screening method for breast cancer, and according to the literature, mammographic screening has reduced mortality from this disease by up to 45%(2,3).
In view of the above limitations of mammographic screening, the role of a personalized approach to breast cancer screening is currently being emphasized and the search for optimal complementary methods to detect more cancers, especially in dense breasts, continues.
Hand-held ultrasonography (HHUS), performed by a radiologist or another specialty doctor skilled in breast examination, is one of the oldest, basic and currently most widely available methods. This method uses an ultrasound wave instead of ionizing radiation. Ultrasound used as a complementary tool in screening and ever yday clinical practice has been shown to significantly improve cancer detection in breasts with dense glandular structure(9) – by 4 –8% according to literature data(10). Despite its wide availability, the method has many limitations. Difficult to eliminate disadvantages of HHUS, such a s lack of standardization, operator-dependent interpretation, small field of view (FOV) and, finally, being a time-consuming procedure (the time of performing an examination significantly exceeds the time of interpreting the obtained images) have been identified. Ultrasound requires extensive knowledge and experience in breast examination, which is essential for the detection of pathology and differentiation between benign and malignant changes. The operator should be able to differentiate focal changes from anatomical structures and artifacts that mimic pathologies, which can be easily generated and misinterpreted by an inexperienced operator.
Ultrasonography allows for the assessment of vascularization of the lesion and the course of both internal and external vessels using power Doppler. Elastography is complementary to ultrasound examination and allows for the analysis of lesion stiffness and estimation of the probability of malignancy on this basis.
Targeted breast biopsy can easily be performed under ultrasound guidance: fine-needle aspiration (BAC) (Fig. 2), core needle biopsy (BGI) (Fig. 3), as well as vacuum assisted breast biopsy (VABB) (Fig. 4).
Ultrasound-guided fine needle biopsy
Thick-needle biopsy of one of the lesions in a patient from Fig. 1
Vacuum-assisted thick-needle biopsy
Considering the advantages and limitations of mammography and ultrasound, breast magnetic resonance imaging (BMRI)(11, 12, 13) h as been used to improve the diagnosis of breast cancer. Just like ultrasound, BMRI does not use ionizing radiation. An intravenous contrast agent is needed to evaluate breast lesions as this examination analyses the pathological vascularization of the tumor based on software-generated patterns of contrast enhancement curves. The scanning must be performed in the appropriate phase of the menstrual cycle, when the level of sex hormones does not cause too much excitation and contrast uptake by the background parenchymal enhancement (BPE) tissues. The lack of contrast agent does not allow an assessment of pathological foci of contrast enhancement in the breast, making the technique non-diagnostic for cancer. A special coil dedicated to breast examination is needed to perform BMRI. The examination is performed in a prone position. Additionally, T2-weighted images are needed to determine the type of breast structure, and T1-weighted images must be taken to assess markers in the breast. Although BMRI is a very sensitive method, its specificity is lower. To improve it, diffusion-weighted imaging (DWI) and apparent diffusion coefficient
Cancer on BMRI in a patient from Fig. 1.
Specific indications for BMRI have been developed, such a s: preoperative staging in patients with newly diagnosed breast cancer, monitoring breast cancer response in patients on neoadjuvant chemotherapy, postoperative assessment of residual tumor mass in patients with positive margins, search for primary lesion in patients with metastatic axillary lymph node, negative mammographic and ultrasound findings (including contrast enhanced spectral mammography (CEM); and digital breast tomosynthesis (DBT)), screening of women at high risk of breast cancer (known
VABB can be performed under BMRI guidance (Fig. 6); however, due to the poor availability and the length of the procedure, only lesions that are not visible on RUSG and mammography qualify for this biopsy.
MRI-guided biopsy. T1-weighted images after contrast administration with a visible biopsy needle
Digital breast tomosynthesis (DBT) and contrast-enhanced spectral mammography (CESM) are novel methods based on mammography. Tomosynthesis is a type of mammography in which an x-ray tube with limited angular range moves in an arc over a compressed breast. In DBT, the reconstruction process creates planes parallel to the detector. If a lesion is located closer to a given plane, it becomes more visible in this plane and will not be missed by mammography (Fig. 7). Additionally, DBT can reduce the phenomenon of tissue summation mimicking a focal lesion, which is present in FFDM, and reduce the number of false positives. In computer reconstructions, thin layers (up to 1 mm thick) are produced, which allow an accurate assessment of focal lesions, as well as summation images up to 10 mm thick, the so-called slabs, which show microcalcifications in a more accurate way. Although DBT is currently not widely available, preliminary studies and publications suggest that it contributes to cancer detection rates more than FFDM(14, 15, 16, 17, 18). The dose of ionizing radiation per patient is the same as in 2D mammography. The indications for tomosynthesis include an evaluation of equivocal findings on FFDM, as well as search for focal lesions in both patients with dense breasts and symptomatic patients with negative FFDM. The fact that it is still a mammographic technique and some of the lesions (visible only on ultrasound or BMRI) may be elusive on DBT is a limitation of this modality. Its low availability is also a disadvantage.
Tomosynthesis planes in CC projection (
Contrast-enhanced spectral mammography (CESM), which is performed after intravenous administration of iodine contrast agents(19,20), is another FFDM-based method. The sensitivity and specificity of this technique are comparable to those of BMRI. CEM is performed using a special dual energy mammograph for low- and high-energy exposures. The examination is analogous to FFDM – each breast is imaged in two projections. Diagnostic stations produce low-energy images corresponding to FFDM and subtractive images, in which the glandular tissue is suppressed and only contrast-enhanced foci remain (Fig. 8). Contrast-enhanced spectral mammography is a method that combines mammography (thus enabling the assessment of the morphology of focal lesions, such as tumors, architectural abnormalities and microcalcifications) with functional imaging after the administration of a contrast agent, where areas of contrast enhancement showing the features of neovascularization in focal lesions are analyzed. Indications include a preoperative assessment of multifocal lesions in patients with known breast cancer, search for focal lesions in symptomatic patients, negative ultrasonographic and FFDM findings, evaluation of equivocal findings on other imaging modalities, as well as screening of patients with dense breasts or at high risk for breast cancer. Slightly higher dose of ionizing radiation per patient than in mammography is a limitation of CEM. The need for contrast agent is an additional burden. This examination must be carefully performed as poor positioning in mammography can lead to lesions being missed out.
CEM – images showing enhancement (subtractive). Scanning performed in a patient from Fig. 1
Automated breast ultrasound (ABUS), a computer-assisted technique for assessing the whole breast using an automated linear 6–14 MHz transducer selected according to breast thickness, is a test that has been developed relatively recently and is now occasionally used. The transducer moves automatically over the breast in a manner similar to HHUS, obtaining transverse plane images in overlapping linear rows in the CC projection (Fig. 9).
ABUS projections in a patient from Fig. 1. Frontal plane showing the ductal system of the breast (
During the examination, a sponge wedge is placed under the patient’s arm in the supine position. This allows for an even distribution of breast tissue, with the nipple pointing towards the ceiling. Hypoallergenic fluid is distributed evenly over the breast, with an additional amount in the nipple area to ensure proper contact between the probe and the breast. During image acquisition, women must not move and should breathe quietly. Scanning by ABUS is continuous and automatic.
Female breasts are symmetrical organs with different sizes (a variable aspect in the population), shapes and densities. The receptor plate is not designed to fit all breasts, and peripheral areas may be missed out. In order to cover the entire breast, electroradiologists choose the most appropriate setting for each patient, depending on breast size.
During an ABUS examination, three volumes are obtained for each breast: frontal (anterior-posterior) with the nipple in the center of the image, lateral, which includes the upper outer part of the breast tissue with the nipple located in the lower-middle corner, and central, which includes the inner and lower part of the breast tissue. The technician also marks the nipple in the image, allowing a more accurate assessment of the breast. Additional views of the upper and lower parts of the breast are required for large breasts.
Each of the three projections is obtained in up to 300 2D images, which are then used for a multiplanar reconstruction of the entire breast, from the skin to the chest wall. In particular, the frontal plane, also known as the ‘surgical plane’, is essential in the review phase. In fact, the standardized revision process for quick navigation is based on the frontal plane.
During the scan, its depth should be assessed to ensure that both the deep and peripheral parts of the breast tissue are contained within the imaging field and should range from 3.5 to 5 cm, depending on breast size for small, medium and large breasts respectively.
Normally, three 1-minute scans are sufficient to scan the whole breast excluding the axillary fossa. The average overall time for a full examination is approximately 15 minutes.
Once acquired by technicians, the data are saved and transferred to diagnostic stations, where radiologists can review them using both original and reconstructed scans at any time. Hence, because images can be reviewed retrospectively, ABUS increases reproducibility, as well as reduces operator dependence and physician time.
ABUS is a technique that separates the moment of image acquisition (performed in ABUS by an electro-radiology technician) from the moment of image interpretation (performed by a radiologist), thus reducing operator dependence as well as physician’s time. The examination can be repeatedly reviewed by many physicians at different times, so the technique was developed to standardize breast ultrasound and eliminate some of the limitations of RUSG, such as operator dependence and examination time(21). Compared to HHUS, the ABUS technique has a larger FOV and can produce multiplanar reconstructions, including 3D, which allows focal lesions to be assessed in different planes and characterized more accurately, as well as providing new diagnostic data.
One of the most significant conveniences of ABUS is the ability to obtain a frontal reconstruction – the breast is visible in this plane as on the operating table, which is why it is referred to as the “surgical plane”. This view improves the assessment of lesion margins. The frontal plane allows reconstruction of the ductal system of the whole breast, which facilitates the detection of ductal dilatation associated with intraductal papillary lesions and even ductal carcinoma in situ by detecting intraluminal echoes in dilated milk ducts. Benign lesions are often surrounded by a continuous hyperechoic border, whereas malignant lesions often have a discontinuous and irregular hyperechoic border that corresponds to a desmoplastic reaction. In this plane, the retraction phenomenon and the desmoplastic reaction are also more pronounced – characteristics of malignant lesions infiltrating the surroundings, which can be described as “black holes” in the reconstruction in the frontal plane (these phenomena are manifested by straight hyper-echoic lines radiating from the center of the tumor). The retraction phenomenon has been shown to be associated with smaller tumor size, lower grade and positive receptor status.
ABUS provides accurate and reproducible data on breast lesion location, size and assessment of ultrasound features, which is invaluable for comparison with examinations of different modalities, as well as in clinical situations requiring follow-up imaging.
Peripherally located lesions may be missed out in ABUS. This technical drawback reduces the diagnostic performance of the method compared to HHUS, especially in large breasts, and may account for cancer misdiagnosis. The electroradiologist should be aware of this aspect and scan the whole breast, obtaining additional acquisitions from the upper and lower parts of the breast.
The main limitation of ABUS is the inability to assess the axillary region and the lack of data on the nodal status. 3In women with small breasts, only the base floor of the axillary fossa can be included in the examination.
Another disadvantage is the lack of tools to assess vascularization and elasticity of breast tissue. However, there is some progress in this area. Hendriks
Additionally, the inability to perform invasive procedures is an important limitation, so lesions detected with ABUS and requiring further evaluation should be reassessed with RUSG. Although the effectiveness of ABUS has been demonstrated in many studies, artifacts may reduce diagnostic value.
Creasing (or rippling) is one of the most common artifacts. Since it is generated by respiratory movements, it is very important that the patient does not cough or talk during the examination. It is also crucial to ensure uniform compression and adequate positioning of the breast and to avoid insufficient gel application. Shadowing that occurs at the border of fat lobules due to the failure to implement the above measures is another important artifact.
Standard ultrasound gel is not used for ABUS due to potential artifacts that can be caused by small gas bubbles. To avoid this, a gel (liquid) specially developed for this purpose, which has the consistency of a homogeneous lotion, is used(24). If the lotion used is not evenly distributed and is missing in some regions, air enters between the transducer and the skin, sound waves are reflected by the air between the transducer membrane and the skin, causing shadowing, and visualization of the underlying glandular tissue becomes impossible.
If the transducer is not evenly and sufficiently pressed against the breast, air is introduced at the edges of image acquisition, making the analysis of glandular parenchyma at the periphery difficult. Insufficient compression may also cause artifacts caused by Cooper’s ligaments, which may be reduced by adequate compression performed by the electroradiologist.
So far, ABUS has been shown to improve breast cancer screening detection rates and sensitivity when used as an adjunct tool to mammography compared to mammography alone.
Tabár
Wilczek
Compared with HHUS, ABUS is still under investigation for various clinical aspects: detection rates and characteristics of breast lesions, diagnostic efficiency, sensitivity and specificity, inter-observer concordance, and use in preoperative diagnosis or
Vourtsis
Depretto
Breast cancer. ABUS (
In their study including 213 patients, Wang
In their prospective clinical study, Hellgrena
Some studies have looked at the effectiveness of ABUS compared with HHUS in the preoperative assessment of cancer. ABUS was more accurate than HHUS in assessing the extent of disease and the size of malignant lesions, with the estimated diameter and total volume being the most important parameters in the preoperative assessment of the true extent of the lesion(32).
Mammography is the primary screening method for breast cancer, with a proven contribution to reduced breast cancer mortality, and is considered the “gold standard”. There are many methods that are valuable adjuncts to mammography, but ABUS, as an ultrasound technique overcoming many disadvantages of HHUS, is emerging as a promising tool to detect more cancers compared to mammography alone, especially in dense glandular breasts.